1 / 38

Cancer Biology

Cancer Biology. Tumour Markers Prof. Kenneth Bagshawe FRS. Tumour Markers Widest Definition. The concept of tumour markers can mean anything that helps in the diagnosis of cancer In a more restricted sense it refers to the biochemical detection of cancer. Imaging Techniques.

umed
Télécharger la présentation

Cancer Biology

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Cancer Biology Tumour Markers Prof. Kenneth Bagshawe FRS

  2. Tumour MarkersWidest Definition • The concept of tumour markers can mean anything that helps in the diagnosis of cancer • In a more restricted sense it refers to the biochemical detection of cancer

  3. Imaging Techniques Detected by: x-ray +/- contrast media Ultra sound   Computerised Tomography (CT) Magnetic resonance imaging (MRI) Gamma Camera and radioisotopes (Nuclear Medicine)

  4. Cannon Ball

  5. Multiple Metastases

  6. Diffuse Metastases-Before and After Chemotherapy

  7. Detection of Tumour Markers • Those detected on cancer tissue i) Biochemical methods Oestrogen receptors in breast cancer ii) Genetic methods Mutated genes BRCA1 and BRCA2 in breast cancer iii) Antibody methods Carcinoembryonic antigen (CEA)

  8. Secreted by cancers into the blood Detection by: • Biochemical techniques steroids in adrenocortical cancer  • Immunoassay proteins, glycoproteins

  9. Ancient History • 1848 Bence Jones Multiple myeloma • 1929 Ascheim-Zondek hCG-trophoblast • 1932 Harvey Cushing Pituitary Basophils

  10. The First Tumour Marker • It is known as Bence –Jones proteinuria, a marker for multiple myeloma a malignancy of the plasma cell. Often referred to as a paraproteinuria • It is a monoclonal gammopathy with any class of immunoglobulin

  11. Adrenocortical Phaeochromocytoma Insulinoma Gastrinoma Carcinoid Medullary Ca Thyroid Cortisol adrenaline & nor adrenaline insulin, C peptide gastrin 5-HIAA Calcitonin Cancers of Endocrine Organs

  12. Ectopic product syndromes • Cancers sometimes produce substances inappropriate to the cell type of origin • Bronchial carcinomas may produce ACTH, parathormone and human Chorionic Gonadotrophin (hCG)

  13. Protein markers of common cancers detected by immunossay in blood • Human Chorionic gonadotrophin (hCG) Pregnancy Trophoblastic disease - Choriocarcinoma Germ cell cancers of testis and ovary • Alfa- feto protein (AFP) Germ cell cancers of testis and ovary Hepatoma

  14. Protein markers continued • Carcinoembryonic antigen (CEA) Colon, stomach etc • Prostate Specific antigen (PSA) CA125- Ovary CA153- Breast

  15. Measurement of Tumour Markers • 1930-1963 Bioassays on Urine • 1958 Immunoassays- serum • 1960 Radioimmunoassay- serum or urine • 1968 Immunometric assay serum or urine- Commercial Kits • 1975 Dip Stick Tests

  16. What Is An Assay ? Unknown

  17. Antibody Production Immunogen (Antigen) Rabbit Sheep Antiserum Mouse Horse etc Antisera contain many different antibodies directed at one or more sites on immunogen (polyclonal) Burnett (1957)- Clonal selection Theory One Cell - identical antibodies

  18. Antibody Production • Kohler & Milstein (1975) Immortalise an antibody producing cell by fusion with a malignant cell • Hybridoma Hybridomas proliferate Identical (monoclonal) antibodies

  19. RISING levels of these serum markers indicate disease progression • FALLING levels and slowing of rate of increase may indicate response to therapy • BUT interpretation has to take account of the HALF -LIFE (t1/2)

  20. Half Life Of Common Tumour Markers Depends On Molecular Weight • MW TM T1/2(D) ROUTE • <70 hCG, PSA 2.3 renal • 70 aFP 6 mixed • > 70 all others 10 hepatic

  21. Median Doubling Timesreflect different growth rates of cancers • CANCER TM T2(D) • Choriocarcinoma hCG 3 • Germ cell aFP 6 • Breast CA153, CEA 30 • Ovary CA125 30 • Pancreas CA199 30 • Colon CEA, CA199 30 • Prostate PSA 128

  22. Cell Numbers

  23. Time Scale- Cell Numbers

  24. Human Chorionic Gonadotrophin-(HCG) C-Terminal Peptide

  25. Normal Placental Villi

  26. hCG V Cell Numbers

  27. Human Chorionic Gonadotrophin (hCG) Normal Pregnancy: Mostly Intact molecule (α and β subunits) Mole, Choriocarcinoma: Fragmented hCG molecules

  28. Trophoblastic Tumour

  29. Choriocarcinoma

  30. Germ Cell Tumour

  31. Germ Cell Tumour

  32. Prostate Specific Antigen (PSA): Age Effect

  33. Carcinoembryonic Antigen

  34. CEA

  35. Radioimmunolocalisation-CEA

  36. Therapeutic Application Radiolabelled Antibodies (RIT) Drug-Antibody Conjugates

  37. Problems • Only a fraction of the i.v injected antibody gets into tumour: Most of the antibody stays in blood until excreted or metabolised • Heterogeneity of cancer cell: not all cancer cells express the marker

  38. Potential Solutions • Antibody directed enzyme prodrug therapy (ADEPT)

More Related